The frequency of uMRD in Japanese patients with CLL after 24 months of treatment with Venetoclax plus/minus Rituximab in the 2L+ in the real-world setting - Trial UMIN000050967
Access comprehensive clinical trial information for UMIN000050967 through Pure Global AI's free database. This phase not specified trial is sponsored by AbbVie GK and is currently Not yet recruiting. The study focuses on Chronic Lymphocytic Leukemia.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000050967
Not yet recruiting
Trial Details
University Hospital Medical Information Network • UMIN000050967
The frequency of uMRD in Japanese patients with CLL after 24 months of treatment with Venetoclax plus/minus Rituximab in the 2L+ in the real-world setting
Study Focus
Observational
Sponsor & Location
AbbVie GK
Japan
Timeline & Enrollment
N/A
May 20, 2023
N/A
ICD-10 Classifications
Chronic lymphocytic leukaemia of B-cell type
Chronic myelomonocytic leukaemia
Acute myelomonocytic leukaemia
Lymphoid leukaemia
Chronic leukaemia of unspecified cell type
Data Source
University Hospital Medical Information Network
UMIN000050967
Non-Device Trial